Le Lézard
Classified in: Health
Subjects: PDT, SVY, HSP, WOM, BLK

Planned Parenthood of Wisconsin Reminds Women About Importance of Screening During Cervical Cancer Awareness Month and Beyond


MADISON, Wis., Jan. 25, 2021 /PRNewswire/ -- There was a time when cervical cancer was a leading cause of cancer death in the United States, until the Pap test revolutionized detection. Thankfully, since the 1960s, the death rate for cervical cancer has dropped more than 70%. It is in the spirit of that test that Planned Parenthood of Wisconsin urges women not to put off testing or Human papillomavirus (HPV) vaccinations.

While January is Cervical Cancer Awareness Month, anytime is a good time to be screened. Even during the pandemic, Planned Parenthood of Wisconsin's doors are open to provide cervical cancer testing, colposcopy services and HPV vaccines to anyone, regardless of health insurance coverage or ability to pay.

The American Cancer Society (ACS) estimates that 210 Wisconsinites will be diagnosed with invasive cervical cancer in 2021 and more than 14,000 new cases will be diagnosed nationwide. Far more women will be diagnosed with pre-cancer or early-stage cases. Hispanic women in Wisconsin are two times more likely than non-Hispanic women to be diagnosed with cervical cancer, and the rate of cervical cancer is 80% higher among Black women than white women.

"Don't let this pandemic keep taking your health," says Maria Barker, Multicultural Programs Manager for Planned Parenthood of Wisconsin. "The doors of your nearest Planned Parenthood are open to safely deliver the regular screenings and vaccinations that save lives."

Additionally, Black and Latinx women nationwide are one to two times more likely to die from cervical cancer than white women. Older women are also more likely to develop this type of cancer at a rate of 20% once they turn 65. Women are much less likely to develop an invasive form of cervical cancer if they regularly test, according to the ACS.

There are risk factors that can affect a woman's likelihood of developing cervical cancer:

Make an appointment online at ppwi.org or call 1-800-230-PLAN (7526) to schedule.

Spanish translation of statement from Maria Barker, Multicultural Programs Manager Planned Parenthood of Wisconsin:

"ˇNo deje que esta pandemia siga quitándole su salud! Recuerde hacerse los chequeos regulare que salvan vidas, haga cita para hacerse el papanicolaou en una de las clínicas de Planned Parenthood que este en su vecindad. ˇNuestras puertas están abiertas para servirles! Llame al 1-800-230-PLAN (7526) para hacer su cita."

Planned Parenthood of Wisconsin is a nonprofit health care provider serving 60,000 patients annually at 24 health centers. Planned Parenthood provides the full range of comprehensive reproductive health care including well woman exams, breast and cervical cancer screenings, STD testing and treatment, birth control and abortion care.

Contact: Amanda Finn
(262) 443 - 2335 
[email protected] 

SOURCE Planned Parenthood of Wisconsin


These press releases may also interest you

at 22:03
The report titled "Carbon Dioxide Incubator Market by Product (Air Jacketed CO2 Incubators, Direct Heat CO2 Incubators, Water Jacketed CO2 Incubators), Capacity (100-200 Litre, Above 200 Litre, Below 100 Litre), Application, End User - Global...

at 22:00
The "Global Clinical In Vitro Diagnostic Medical Laboratory Services Market: Strategy & Trends with Volume & Price Forecasts by Chemistry, Hematology, Microbiology, Pathology, Covid-19, and Molecular Dx by Country. Updated with Impact of COVID-19"...

at 21:45
The "Molecular Diagnostics at the Point of Care. By Application, Technology, Place, Product and by Country. With Executive Guides and Customization 2023 - 2027 " report has been added to  ResearchAndMarkets.com's offering. Infectious disease Dx is...

at 21:30
The "Whole Genome and Exome Sequencing Markets by Application, Organism and Product with Executive and Consultant Guides. Includes Direct to Consumer Analysis. 2023 to 2027" report has been added to  ResearchAndMarkets.com's offering. Will all...

at 20:50
Pharma (1167.HK), a clinical-stage oncology company drugging the undruggable targets, today announced its 2023 annual results. The revenue was RMB63.5 million, the R&D investment was RMB372 million, the cash and cash equivalent at the end of 2023 was...

at 20:35
InnoCare Pharma (HKEX: 09969; SSE: 688428), a leading biopharmaceutical company announced that the first patient in China has been dosed in the Phase 1b clinical study of the combination of InnoCare's novel SHP2 (Src Homology 2 domain containing...



News published on and distributed by: